Skip to main content

Health condition · Clinically reviewed

Oesophageal cancer, why progressive dysphagia should never wait.

Difficulty swallowing that moves from solids to liquids is the symptom that matters most. Early referral, endoscopy and staging shape everything that follows.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against NICE NG12 and NG83, and specialist upper GI cancer standards you can see at the end.

  • 03

    Current for 2026

    Reflects modern UK practice including 2-week-wait pathways, OGD, staging and MDT-led treatment.

Key facts

Oesophageal cancer at a glance.

The essentials, in plain English - the two main types, the key test, and how treatment is decided in the UK today.

  • What it is

    A cancer of the oesophagus, arising as adenocarcinoma or squamous cell carcinoma, most often diagnosed after progressive difficulty swallowing.

  • Two main types

    Adenocarcinoma, increasingly common and linked to Barrett’s oesophagus and reflux, usually lower third. Squamous cell carcinoma, linked to smoking and alcohol, usually upper or middle third.

  • Key red flag

    Progressive dysphagia, difficulty swallowing solids that moves on to liquids, is the symptom that should never wait.

  • Key test

    Upper GI endoscopy (OGD) with biopsy confirms the diagnosis and cell type in almost every case.

  • Staging

    CT or PET-CT and endoscopic ultrasound map the tumour and any spread, sometimes alongside staging laparoscopy.

  • Treatment

    Stage-dependent: surgery with neoadjuvant chemotherapy or chemoradiotherapy, definitive chemoradiotherapy, or palliative care with stenting for advanced disease.

Why this guide matters

Early recognition changes outcomes.

Oesophageal cancer is often diagnosed late because early symptoms are easy to dismiss. The three points below shape everything else on this page.

  • Dysphagia is the symptom that matters

    Difficulty swallowing solids that progresses to liquids should always trigger an urgent 2-week-wait referral, not watchful waiting.

  • OGD with biopsy confirms everything

    A single endoscopy with tissue sampling identifies the cancer and its cell type, setting the whole treatment pathway in motion.

  • Treatment is stage-dependent, not fixed

    From curative surgery to palliative stenting, the right plan depends entirely on staging - which is why specialist MDT input matters.

How the diagnosis is made

From first symptoms to a staged treatment plan.

The steps a UK GP and specialist upper GI cancer team will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    Recognising the symptoms

    Progressive dysphagia (solids then liquids), unintentional weight loss, retrosternal discomfort, odynophagia, persistent reflux or new hoarseness prompt assessment.

  2. 02

    Assessing

    GP assessment

    History of reflux, smoking, alcohol use and weight change, plus examination for an upper abdominal mass or supraclavicular lymph nodes.

  3. 03

    Assessing

    Urgent 2-week-wait referral

    NICE NG12 recommends urgent referral for dysphagia of any age, or for an upper abdominal mass consistent with a gastric or oesophageal cancer.

  4. 04

    Confirming

    OGD endoscopy with biopsy

    Direct visualisation of the oesophagus with tissue sampling is the key diagnostic test, confirming cell type (adenocarcinoma or squamous cell carcinoma).

  5. 05

    Confirming

    CT and PET-CT staging

    Cross-sectional imaging looks for local invasion, nodal spread and distant metastases, guiding whether surgery is a realistic option.

  6. 06

    Confirming

    Endoscopic ultrasound and laparoscopy

    EUS refines local tumour and nodal staging. Staging laparoscopy is used in some cases, particularly for lower oesophageal and junctional tumours, to exclude peritoneal disease.

  7. 07

    Planning

    Specialist upper GI cancer MDT

    A multidisciplinary team at a specialist commissioned centre agrees the treatment plan, resectability, and the role of nutritional and dietetic support.

Typical timeline: urgent referral to a confirmed treatment plan within a few weeks.

Symptoms

What oesophageal cancer actually feels like.

The classic mix of progressive dysphagia, weight loss and chest discomfort. And the features that mean it's time to act urgently.

  • Progressive dysphagia

    Difficulty swallowing that starts with solids and progresses to liquids is the classic and most important warning sign.

  • Unintentional weight loss

    Weight loss without trying, often alongside reduced food intake because swallowing has become uncomfortable or difficult.

  • Retrosternal chest discomfort

    A dull ache or pressure behind the breastbone, sometimes mistaken for reflux or cardiac pain.

  • Persistent reflux symptoms

    Longstanding or worsening heartburn and acid regurgitation, particularly in those with known Barrett’s oesophagus.

  • Odynophagia

    Pain on swallowing, distinct from the mechanical difficulty of dysphagia, and a marker of more advanced local disease.

  • Hoarseness

    A change in voice can signal involvement of the recurrent laryngeal nerve and warrants prompt specialist assessment.

  • Regurgitation and coughing

    Undigested food coming back up, or coughing after eating, particularly when lying flat, can reflect a narrowing oesophagus.

  • Red flag, dysphagia at any age

    NICE guidance is clear: dysphagia of any age is an urgent 2-week-wait referral, not a watch-and-wait symptom.

Treatment

How oesophageal cancer is treated in the UK.

Surgery with neoadjuvant therapy for resectable disease, definitive chemoradiotherapy for non-surgical candidates, and palliative options plus nutritional support for advanced disease.

  • Oesophagectomy

    Surgical removal of the affected oesophagus for resectable disease, usually performed at a specialist upper GI cancer centre.

  • Neoadjuvant chemotherapy

    Chemotherapy given before surgery to shrink the tumour and improve the chance of complete resection.

  • Neoadjuvant chemoradiotherapy

    Combined chemotherapy and radiotherapy before surgery, particularly favoured for squamous cell carcinoma and some junctional tumours.

  • Definitive chemoradiotherapy

    Combined chemotherapy and radiotherapy given with curative intent for those who are not surgical candidates.

  • Oesophageal stenting

    A palliative measure to relieve dysphagia and restore swallowing in advanced or inoperable disease.

  • Palliative chemotherapy

    Used to control symptoms and slow disease progression when cure is not possible.

  • Palliative radiotherapy

    Targeted radiotherapy to relieve local symptoms such as pain, bleeding or obstruction.

  • Nutritional support

    Dietitian-led input is crucial throughout, from pre-operative optimisation to managing dysphagia and maintaining weight during treatment.

What this guide is based on

The sources behind every claim on this page.

UK national guidance and specialist upper GI cancer standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your GP or specialist knows your history and can tell you which parts apply to you. If you have swallowing difficulty, get seen.

  • NICE. Suspected cancer: recognition and referral (NG12).

  • NICE. Oesophago-gastric cancer: assessment and management in adults (NG83).

  • Royal College of Radiologists and specialist upper GI cancer MDT standards.

  • Cancer Research UK. Oesophageal cancer statistics and treatment overview.

Red flags

When swallowing problems need urgent attention.

Many swallowing symptoms are benign. These are the situations that need urgent 2-week-wait referral or same-day assessment.

  • Dysphagia at any age

    Progressive difficulty swallowing, especially solids moving to liquids, is the single most important symptom and needs urgent 2-week-wait referral.

  • Upper abdominal mass

    A palpable mass consistent with an upper GI cancer needs the same urgent referral pathway as dysphagia.

  • Unexplained weight loss with GI symptoms

    Weight loss combined with reflux, dyspepsia or dysphagia should not be attributed to lifestyle alone without investigation.

  • Iron deficiency anaemia in over-55s

    Unexplained anaemia in this age group, particularly with upper GI symptoms, warrants prompt endoscopic assessment.

  • New hoarseness with swallowing problems

    Suggests possible recurrent laryngeal nerve involvement from a more advanced tumour, needing urgent specialist review.

  • Haematemesis or melaena

    Vomiting blood or passing black tarry stools alongside swallowing symptoms is an emergency needing same-day assessment.

  • Longstanding Barrett’s with new symptoms

    Any new dysphagia, weight loss or bleeding in a known Barrett’s oesophagus patient should prompt urgent re-assessment, not routine surveillance alone.

  • Recurrent aspiration pneumonia

    Repeated chest infections from food or fluid entering the airway can reflect a significantly narrowed oesophagus.

  • Persistent odynophagia

    Pain on swallowing that does not settle needs the same urgency as dysphagia rather than a trial of antacids.

Living with it

Support through treatment, and beyond it.

Four things that make the biggest difference through diagnosis and treatment - good nutrition, early reporting of new symptoms, a supportive team, and staying on top of follow-up.

A quiet reminder

You don't have to manage this alone.

Specialist nurses, dietitians and your MDT are there throughout, not just at diagnosis.

  1. 01 Nutrition

    Dietitian input from the start

    Specialist dietetic support helps maintain weight and manage textures as swallowing changes through treatment.

  2. 02 Symptoms

    Report new swallowing changes early

    Any worsening dysphagia, pain or weight loss during or after treatment should be flagged promptly to the MDT.

  3. 03 Support

    Lean on the wider team

    Upper GI cancer nurse specialists, dietitians and psychological support all play a part in day-to-day coping.

  4. 04 Follow-up

    Keep surveillance appointments

    Regular review after treatment allows early detection of recurrence and ongoing management of nutrition and symptoms.

Frequently asked

Everything we get asked about oesophageal cancer.

Quick answers on symptoms, diagnosis, the link to reflux, and treatment options.

  • What is oesophageal cancer?

    A cancer arising in the lining of the oesophagus, the tube connecting the throat to the stomach. There are two main types: adenocarcinoma, increasingly common and linked to Barrett’s oesophagus and reflux, usually affecting the lower third, and squamous cell carcinoma, linked to smoking and alcohol, usually affecting the upper or middle third.

  • What is the earliest warning sign?

    Progressive dysphagia, difficulty swallowing that starts with solid food and gradually affects liquids too, is the classic early warning sign. It should always prompt an urgent 2-week-wait referral rather than a wait-and-see approach.

  • How is oesophageal cancer diagnosed?

    The key test is an upper GI endoscopy (OGD) with biopsy, which allows direct visualisation of the oesophagus and confirms the cell type. Staging is then completed with CT or PET-CT, endoscopic ultrasound, and sometimes staging laparoscopy.

  • Is oesophageal cancer linked to reflux?

    Adenocarcinoma, the more common type in the UK, is strongly linked to long-standing gastro-oesophageal reflux disease and Barrett’s oesophagus. Squamous cell carcinoma is more closely linked to smoking and alcohol rather than reflux.

  • What treatments are available?

    Treatment depends on the stage. Resectable disease is usually treated with surgery (oesophagectomy), often after neoadjuvant chemotherapy or chemoradiotherapy. Non-surgical candidates may have definitive chemoradiotherapy. Advanced disease is managed palliatively with stenting, chemotherapy or radiotherapy, alongside nutritional support.

  • Why is nutritional support so important?

    Dysphagia makes eating difficult well before and during treatment, so dietitian-led support helps maintain weight, manage food textures, and sometimes involves feeding tubes. Good nutrition also supports recovery from surgery and tolerance of chemotherapy or radiotherapy.

Related content

Keep reading.